Article info

Download PDFPDF

Extended report
The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor

Authors

  1. Correspondence to Dr Leslie R Harrold, Department of Orthopedics, University of Massachusetts Medical School, 55 Lake Ave North, Worcester, MA 01655, USA; Leslie.Harrold{at}umassmed.edu
View Full Text

Citation

Harrold LR, Reed GW, Kremer JM, et al
The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor

Publication history

  • Received May 12, 2013
  • Revised September 10, 2013
  • Accepted November 10, 2013
  • First published December 2, 2013.
Online issue publication 
January 07, 2015

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.